Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3

Nucleic Acids Research

Volumn 33, Issue 17, 2005, Pages 5521-5532

  Matilainen, Merja ^a   Malinen, Marjo ^a   Saavalainen, Katri ^a   Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; RETINOID X RECEPTOR; RNA POLYMERASE II; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; VITAMIN D RECEPTOR;

ARTICLE; BONE CANCER; CANCER CELL; CELL CULTURE; CELL LEVEL; CHROMATIN; COMPUTER MODEL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; GENE TARGETING; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MITOGENICITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA EXTRACTION; VITAMIN D RESPONSIVE ELEMENT; BIOSYNTHESIS; BONE TUMOR; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE;

BONE NEOPLASMS; CALCITRIOL; CELL LINE, TUMOR; CHROMATIN; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; PROSTATIC NEOPLASMS; VITAMIN D RESPONSE ELEMENT;

EID: 26944435954     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki872     Document Type: Article

References (38)

1. Sutton,A.L. and MacDonald,P.N. (2003) Vitamin D: More than a 'bone-a-fide' hormone. Mol. Endocrinol., 17, 777-791.
2. 3 and its analogs on growth control and tumorigenesis. Front. Biosci., 6, D820-D848.
3. Jones,G., Strugnell,S.A. and DeLuca,H.F. (1998) Current understanding of the molecular actions of vitamin D. Physiol. Rev., 78, 1193-1231.
4. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10, 142-153.
5. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp. Cell Res., 209, 367-374.
6. 3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J. Biol. Chem., 274, 8437-8444.
7. Xie,S.P., Pirianov,G. and Colston,K.W. (1999) Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur. J. Cancer, 35, 1717-1723.
8. Colston,K.W., Perks,C.M., Xie,S.P. and Holly,J.M. (1998) Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J. Mol. Endocrinol., 20, 157-162.
9. 3. Oncogene, 23, 4856-4861.
10. Peng,L., Malloy,P.J. and Feldman,D. (2004) Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol. Endocrinol., 18, 1109-1119.
11. Hwa,V., Oh,Y. and Rosenfeld,R.G. (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev., 20, 761-787.
12. Lee,K.W., Ma,L., Yan,X., Liu,B., Zhang,X.K. and Cohen,P. (2005) Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J. Biol. Chem., 280, 16942-16948.
13. 3. Crit. Rev. Eukaryot. Gene Expr., 8, 19-42.
14. Quack,M. and Carlberg,C. (2000) Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J. Mol. Biol., 296, 743-756.
15. Carlberg,C., Bendik,I., Wyss,A., Meier,E., Sturzenbecker,L.J., Grippo,J.F. and Hunziker,W. (1993) Two nuclear signalling pathways for vitamin D. Nature, 361, 657-660.
16. 3R receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature, 370, 382-386.
17. 3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell Biol., 15, 1154-1161.
18. 3. J. Mol. Biol., 350, 65-77.
19. 3 - responsive regions in its promoter. Nucleic Acid Res., 33, 2440-2451.
20. Burke,L.J. and Baniahmad,A. (2000) Co-repressors 2000. FASEB J., 14, 1876-1888.
21. 3 receptor-corepressor partnership. FASEB J., 14, 1455-1463.
22. Leo,C. and Chen,J.D. (2000) The SRC family of nuclear receptor coactivators. Gene, 245, 1-11.
23. Castillo,A.I., Jimenez-Lara,A.M., Tolon,R.M. and Aranda,A. (1999) Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol. Endocrinol., 13, 1141-1154.
24. Fondell,J.D., Guermah,M., Malik,S. and Roeder,R.G. (1999) Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl Acad. Sci. USA, 96, 1959-1964.
25. Rachez,C., Lemon,B.D., Suldan,Z., Bromleigh,V., Gamble,M., Näär,A.M., Erdjument-Bromage,H., Tempst,P. and Freedman,L.P. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398, 824-828.
26. Levin,A.A., Sturzenbecker,L.J., Kazmer,S., Bosakowski,T., Huselton,C., Allenby,G., Speck,J., Kratzeisen,C., Rosenberger,M., Lovey,A. et al. (1992) 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature, 355, 359-361.
27. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem. Biophys. Res. Commun., 218. 882-886.
28. Toell,A., Polly,P. and Carlberg,C. (2000) All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem. J., 352, 301-309.
29. Swanti,S., Raghavachari,N., Muller,U.R., Bao,Y.P. and Feldman,D. (2003) Vitamin D growth inhibition of breast cancer cells: Gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat., 80, 49-62.
30. 3 in human colon cancer cells. Cancer Res., 63, 7799-7806.
31. Rozen,F. and Pollak,M. (1999) Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins. Int. J. Oncol., 15, 589-594.
32. Krishnan,A. V., Peehl,D.M. and Feldman,D. (2003) The role of vitamin D in prostate cancer. Recent Results Cancer Res., 164, 205-221.
33. Kelley,K.M., Oh,Y., Gargosky,S.E., Gucev,Z., Matsumoto,T., Hwa,V., Ng,L., Simpson,D.M. and Rosenfeld,R.G. (1996) Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol., 28, 619-637.
34. Yin,P., Xu,Q. and Duan,C. (2004) Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J. Biol. Chem., 279, 32660-32666.
35. Gregory,C.W., Kim,D., Ye,P., D'Ercole,A.J., Pretlow,T.G., Mohler,J.L. and French,F.S.(1999) Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology, 1.40, 2372-2381.
36. Wasserman,W.W. and Sandelin,A. (2004) Applied bioinformatics for the identification of regulatory elements. Nature Rev. Genet., 5, 276-287.
37. Xie,X., Lu,J., Kulbokas,E.J., Golub,T.R., Mootha,V., Lindblad-Toh,K., Lander,E.S. and Kellis,M. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature, 434, 338-345.
38. Ogata,K., Sato,K. and Tahirov,T.H. (2003) Eukaryotic transcriptional regulatory complexes: Cooperativity from near and afar. Curr. Opin. Struct. Biol., 13, 40-48.